Details:

Alternative Title:
Diabetol Metab Syndr
Publisher's site:
http://dx.doi.org/10.1186/s13098-015-0054-z
Personal Author:
Tapley, Jeffrey L. ; McGwin, Gerald ; Ashraf, Ambika P. ; MacLennan, Paul A. ; Callahan, Koula ; ... More +
Tapley, Jeffrey L. ; McGwin, Gerald ; Ashraf, Ambika P. ; MacLennan, Paul A. ; Callahan, Koula ; Searcey, Karen ; Witherspoon, C. Douglas ; Saaddine, Jinan ; Owsley, Cynthia Less -
Description:
Background

We examined the feasibility and efficacy of using a non-mydriatic camera to screen for diabetic retinopathy (DR) among youth with type 1 or type 2 diabetes seen in a pediatric endocrinology clinic serving Alabama, the state that has the highest diabetes rate in the United States.

Methods

236 youths with type 1 or type 2 diabetes were screened for DR using a non-mydriatic camera. Visual acuity was also assessed. A questionnaire asked parents about diabetes and eye care history.

Results

Mean duration since diabetes diagnosis was 5.5 years. 66 % reported receiving an eye examination within the previous year. 97.5 % had images that were gradable. DR was detected in 3.8 % of participants. 9.1 % were visually impaired.

Conclusions

Use of a non-mydriatic fundus camera is feasible and efficacious for DR screening in youth with diabetes. DR screening at routine endocrinology visits may be beneficial in managing youth with diabetes and preventing irreversible vision loss, particularly for those in regions where diabetes rates are high.


Subject:
[+]
Diabetes Complications Diabetes Mellitus Diabetic Retinopathy Pediatrics Research Visual Acuity
Source:
Diabetol Metab Syndr. 7.
Pubmed ID:
26136849
Pubmed Central ID:
PMC4487844
Document Type:
Journal Article
Collection(s):
CDC Public Access
Main Document Checksum:
[+]
urn:sha256:41c632910fe2f906b2983ffdbe7ae21a2937c576b21e45b7aec227344d14bfbc
Download URL:
https://stacks.cdc.gov/view/cdc/31953/cdc_31953_DS1.pdf
File Type:

Supporting Files

• 	13098_2015_Article_54.nxml	txt
  	license.txt	txt

More +